{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:17:49Z","timestamp":1792844269253,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32250710141"],"award-info":[{"award-number":["32250710141"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1601200"],"award-info":[{"award-number":["2017YFC1601200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cryptosporidiosis is a significant diarrheal disease in humans and animals. Immunodeficient mice are the primary small animal models, but their high costs and specialized breeding\/housing requirements limit in vivo drug testing. Numerous anticryptosporidial lead compounds identified in vitro remain untested in vivo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Cryptosporidium tyzzeri, a natural mouse parasite closely related to Cryptosporidium parvum and Cryptosporidium hominis, was isolated to establish an infection model in immunocompetent mice. The model was validated using classic anticryptosporidial drugs (paromomycin and nitazoxanide) and then employed to assess the efficacy of 3 new leads (vorinostat, docetaxel, and baicalein). An in vitro culture of C. tyzzeri was also developed to complement the animal model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Chronic C. tyzzeri infection was established in chemically immunosuppressed wild-type mice. Paromomycin (1000 mg\/kg\/d) and nitazoxanide (100 mg\/kg\/d) demonstrated efficacy against C. tyzzeri. Vorinostat (30 mg\/kg\/d), docetaxel (25 mg\/kg\/d), and baicalein (50 mg\/kg\/d) were highly effective against C. tyzzeri infection. In vitro, nitazoxanide, vorinostat, docetaxel, and baicalein exhibited low to submicromolar efficacy against C. tyzzeri.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Novel in vivo and in vitro models have been developed for cost-effective anticryptosporidial drug testing. Vorinostat, docetaxel, and baicalein show potential for repurposing and\/or optimization for developing new anticryptosporidial drugs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiad243","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T19:03:29Z","timestamp":1688756609000},"page":"1430-1440","source":"Crossref","is-referenced-by-count":12,"title":["Cost-effective In Vivo and In Vitro Mouse Models for Evaluating Anticryptosporidial Drug Efficacy: Assessing Vorinostat, Docetaxel, and Baicalein"],"prefix":"10.1093","volume":"228","author":[{"given":"Mingxiao","family":"Liu","sequence":"first","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory of Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University , Changchun, Jilin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory of Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University , Changchun, Jilin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqiang","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory of Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University , Changchun, Jilin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory of Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University , Changchun, Jilin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory of Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University , Changchun, Jilin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Yin","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory of Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University , Changchun, Jilin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-0659","authenticated-orcid":false,"given":"Guan","family":"Zhu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory of Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University , Changchun, Jilin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"2023111212174983300_jiad243-B1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(14)70772-8","article-title":"A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium","volume":"15","author":"Checkley","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2023111212174983300_jiad243-B2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.pt.2019.12.016","article-title":"A one health approach to tackle cryptosporidiosis","volume":"36","author":"Innes","year":"2020","journal-title":"Trends Parasitol"},{"key":"2023111212174983300_jiad243-B3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4269\/ajtmh.2005.73.54","article-title":"Cryptosporidiosis in HIV-infected Venezuelan adults is strongly associated with acute or chronic diarrhea","volume":"73","author":"Certad","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"2023111212174983300_jiad243-B4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijpara.2020.03.002","article-title":"Long-term production effects of clinical cryptosporidiosis in neonatal calves","volume":"50","author":"Shaw","year":"2020","journal-title":"Int J Parasitol"},{"key":"2023111212174983300_jiad243-B5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vetpar.2008.05.002","article-title":"Prevalence and molecular characterisation of Cryptosporidium and Giardia in lambs and goat kids in Belgium","volume":"155","author":"Geurden","year":"2008","journal-title":"Vet Parasitol"},{"key":"2023111212174983300_jiad243-B6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4269\/ajtmh.2003.68.382","article-title":"Nitazoxanide: an important advance in anti-parasitic therapy","volume":"68","author":"White","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"2023111212174983300_jiad243-B7","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/428839","article-title":"Nitazoxanide: a new thiazolide antiparasitic agent","volume":"40","author":"Fox","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2023111212174983300_jiad243-B8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s12639-022-01513-2","article-title":"Diagnosis and control of cryptosporidiosis in farm animals","volume":"46","author":"Aboelsoued","year":"2022","journal-title":"J Parasit Dis"},{"key":"2023111212174983300_jiad243-B9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s44149-021-00002-y","article-title":"Current status and challenges in drug discovery against the globally important zoonotic cryptosporidiosis","volume":"1","author":"Zhu","year":"2021","journal-title":"Anim Dis"},{"key":"2023111212174983300_jiad243-B10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.exppara.2008.12.014","article-title":"Cryptosporidium: genomic and biochemical features","volume":"124","author":"Rider","year":"2010","journal-title":"Exp Parasitol"},{"key":"2023111212174983300_jiad243-B11","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1128\/IAI.68.4.2315-2322.2000","article-title":"Cryptosporidium parvum induces host cell actin accumulation at the host-parasite interface","volume":"68","author":"Elliott","year":"2000","journal-title":"Infect Immun"},{"key":"2023111212174983300_jiad243-B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1674-8301(11)60001-8","article-title":"Cryptosporidiosis\u2014an overview","volume":"25","author":"Leitch","year":"2012","journal-title":"J Biomed Res"},{"key":"2023111212174983300_jiad243-B13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijpara.2015.07.006","article-title":"Continuous culture of Cryptosporidium parvum using hollow fiber technology","volume":"46","author":"Morada","year":"2016","journal-title":"Int J Parasitol"},{"key":"2023111212174983300_jiad243-B14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.chom.2019.05.007","article-title":"A stem-cell-derived platform enables complete Cryptosporidium development in vitro and genetic tractability","volume":"26","author":"Wilke","year":"2019","journal-title":"Cell Host Microbe"},{"key":"2023111212174983300_jiad243-B15","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41564-018-0177-8","article-title":"Modelling Cryptosporidium infection in human small intestinal and lung organoids","volume":"3","author":"Heo","year":"2018","journal-title":"Nat Microbiol"},{"key":"2023111212174983300_jiad243-B16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3390\/microorganisms8050715","article-title":"Organoids and bioengineered intestinal models: potential solutions to the Cryptosporidium culturing dilemma","volume":"8","author":"Gunasekera","year":"2020","journal-title":"Microorganisms"},{"key":"2023111212174983300_jiad243-B17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1645\/12-42.1","article-title":"Treating Cryptosporidium parvum infection in calves","volume":"99","author":"Nasir","year":"2013","journal-title":"J Parasitol"},{"key":"2023111212174983300_jiad243-B18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijpara.2012.08.004","article-title":"In vitro culture systems for the study of apicomplexan parasites in farm animals","volume":"43","author":"M\u00fcller","year":"2013","journal-title":"Int J Parasitol"},{"key":"2023111212174983300_jiad243-B19","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1080\/21645515.2018.1498436","article-title":"The piglet acute diarrhea model for evaluating efficacy of treatment and control of cryptosporidiosis","volume":"15","author":"Lee","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"2023111212174983300_jiad243-B20","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/infdis\/jix689","article-title":"The existing drug vorinostat as a new lead against cryptosporidiosis by targeting the parasite histone deacetylases","volume":"217","author":"Guo","year":"2018","journal-title":"J Infect Dis"},{"key":"2023111212174983300_jiad243-B21","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1128\/iai.60.8.3325-3331.1992","article-title":"Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice","volume":"60","author":"McDonald","year":"1992","journal-title":"Infect Immun"},{"key":"2023111212174983300_jiad243-B22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-3024.2007.01013.x","article-title":"Humoral immune response in IL-12 and IFN-gamma deficient mice after infection with Cryptosporidium parvum","volume":"30","author":"Jakobi","year":"2008","journal-title":"Parasite Immunol"},{"key":"2023111212174983300_jiad243-B23","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1017\/S0031182008004757","article-title":"High-yield amplification of Cryptosporidium parvum in interferon gamma receptor knockout mice","volume":"135","author":"von Oettingen","year":"2008","journal-title":"Parasitology"},{"key":"2023111212174983300_jiad243-B24","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jit645","article-title":"Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases","volume":"209","author":"Guo","year":"2014","journal-title":"J Infect Dis"},{"key":"2023111212174983300_jiad243-B25","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1128\/AAC.02075-13","article-title":"Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis","volume":"58","author":"Gorla","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2023111212174983300_jiad243-B26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/infdis\/jix247","article-title":"Necessity of bumped kinase inhibitor gastrointestinal exposure in treating Cryptosporidium infection","volume":"216","author":"Arnold","year":"2017","journal-title":"J Infect Dis"},{"key":"2023111212174983300_jiad243-B27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature22337","article-title":"A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis","volume":"546","author":"Manjunatha","year":"2017","journal-title":"Nature"},{"key":"2023111212174983300_jiad243-B28","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1073\/pnas.1814685116","article-title":"Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis","volume":"116","author":"Baraga\u00f1a","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023111212174983300_jiad243-B29","doi-asserted-by":"crossref","first-page":"eaba8412","DOI":"10.1126\/scitranslmed.aba8412","article-title":"Bicyclic azetidines kill the diarrheal pathogen Cryptosporidium in mice by inhibiting parasite phenylalanyl-tRNA synthetase","volume":"12","author":"Vinayak","year":"2020","journal-title":"Sci Transl Med"},{"key":"2023111212174983300_jiad243-B30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chom.2019.05.006","article-title":"A genetically tractable, natural mouse model of cryptosporidiosis offers insights into host protective immunity","volume":"26","author":"Sateriale","year":"2019","journal-title":"Cell Host Microbe"},{"key":"2023111212174983300_jiad243-B31","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3389\/fmicb.2015.00991","article-title":"Quantitative RT-PCR assay for high-throughput screening (HTS) of drugs against the growth of Cryptosporidium parvum in vitro","volume":"6","author":"Zhang","year":"2015","journal-title":"Front Microbiol"},{"key":"2023111212174983300_jiad243-B32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/jac\/dkab369","article-title":"Host cells with transient overexpression of MDR1 as a novel in vitro model for evaluating on-target effect for activity against the epicellular Cryptosporidium parasite","volume":"77","author":"Yang","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2023111212174983300_jiad243-B33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-4939-9748-0_4","article-title":"Cryptosporidium oocyst purification using discontinuous gradient centrifugation","volume":"2052","author":"Arrowood","year":"2020","journal-title":"Methods Mol Biol"},{"key":"2023111212174983300_jiad243-B34","doi-asserted-by":"crossref","first-page":"e00115","DOI":"10.1016\/j.fawpar.2021.e00115","article-title":"Cryptogenotyper: a new bioinformatics tool for rapid Cryptosporidium identification","volume":"23","author":"Yanta","year":"2021","journal-title":"Food Waterborne Parasitol"},{"key":"2023111212174983300_jiad243-B35","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1128\/IAI.05862-11","article-title":"Involvement of host cell integrin alpha2 in Cryptosporidium parvum infection","volume":"80","author":"Zhang","year":"2012","journal-title":"Infect Immun"},{"key":"2023111212174983300_jiad243-B36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-1-4939-9748-0_18","article-title":"High-throughput screening of drugs against the growth of Cryptosporidium parvum in vitro by qRT-PCR","volume":"2052","author":"Zhang","year":"2020","journal-title":"Methods Mol Biol"},{"key":"2023111212174983300_jiad243-B37","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1017\/S0031182014001085","article-title":"Cryptosporidium species in humans and animals: current understanding and research needs","volume":"141","author":"Ryan","year":"2014","journal-title":"Parasitology"},{"key":"2023111212174983300_jiad243-B38","doi-asserted-by":"crossref","first-page":"e1007953","DOI":"10.1371\/journal.ppat.1007953","article-title":"Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum","volume":"15","author":"Li","year":"2019","journal-title":"PLoS Pathog"},{"key":"2023111212174983300_jiad243-B39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.14411\/fp.2003.003","article-title":"Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model","volume":"50","author":"Li","year":"2003","journal-title":"Folia Parasitol (Praha)"},{"key":"2023111212174983300_jiad243-B40","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3389\/fmicb.2019.01999","article-title":"Discovery of novel anti-cryptosporidial activities from natural products by in vitro high-throughput phenotypic screening","volume":"10","author":"Jin","year":"2019","journal-title":"Front Microbiol"},{"key":"2023111212174983300_jiad243-B41","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1128\/AAC.49.11.4437-4442.2005","article-title":"Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro","volume":"49","author":"Cai","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2023111212174983300_jiad243-B42","doi-asserted-by":"crossref","first-page":"e00718-18","DOI":"10.1128\/AAC.00718-18","article-title":"Amixicile reduces severity of cryptosporidiosis but does not have in vitro activity against Cryptosporidium","volume":"62","author":"Bartelt","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2023111212174983300_jiad243-B43","doi-asserted-by":"crossref","first-page":"e0005373","DOI":"10.1371\/journal.pntd.0005373","article-title":"A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis","volume":"11","author":"Love","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2023111212174983300_jiad243-B44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1051\/parasite\/2008153275","article-title":"Drug treatment and novel drug target against Cryptosporidium","volume":"15","author":"Gargala","year":"2008","journal-title":"Parasite"},{"key":"2023111212174983300_jiad243-B45","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/AAC.00614-09","article-title":"Evaluation of new thiazolide\/thiadiazolide derivatives reveals nitro group-independent efficacy against in vitro development of Cryptosporidium parvum","volume":"54","author":"Gargala","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2023111212174983300_jiad243-B46","doi-asserted-by":"crossref","first-page":"e12800","DOI":"10.1111\/pim.12800","article-title":"Development of an immunocompetent mouse model susceptible to Cryptosporidium tyzzeri infection","volume":"43","author":"Huang","year":"2021","journal-title":"Parasite Immunol"},{"key":"2023111212174983300_jiad243-B47","doi-asserted-by":"crossref","first-page":"e0012722","DOI":"10.1128\/iai.00127-22","article-title":"Development of two mouse models for vaccine evaluation against cryptosporidiosis","volume":"90","author":"Dayao","year":"2022","journal-title":"Infect Immun"},{"key":"2023111212174983300_jiad243-B48","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1128\/AAC.42.11.2877","article-title":"Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model","volume":"42","author":"Blagburn","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2023111212174983300_jiad243-B49","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1128\/AAC.49.11.4628-4634.2005","article-title":"Inhibitory activities of epidermal growth factor receptor tyrosine kinase-targeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum development","volume":"49","author":"Gargala","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2023111212174983300_jiad243-B50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpara.2021.10.006","article-title":"Immunocompetent rabbits infected with Cryptosporidium cuniculus as an animal model for anti-cryptosporidial drug testing","volume":"52","author":"Lu","year":"2022","journal-title":"Int J Parasitol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiad243\/50904918\/jiad243.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/10\/1430\/53307854\/jiad243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/10\/1430\/53307854\/jiad243.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T12:18:35Z","timestamp":1699791515000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/228\/10\/1430\/7221292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,7,7]]},"published-print":{"date-parts":[[2023,11,11]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad243","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11,15]]},"published":{"date-parts":[[2023,7,7]]}}}